论文部分内容阅读
肾移植是治疗终末期肾病的有效方法。目前国内某些医院施行肾移植术已取得良好效果,肾移植后病人及移植肾的1年存活率分别为93.3％～93.7％、78.8％～83.7％,达到国际先进水平。但由于免疫学尚未完全解决,异体肾移植后1～6个月 内约有75％的病人可发生1～3次急性排斥,这是导致移植肾丧失功能的主要原因,占肾失功能的73.5％～94.8％。因此,重视急性排斥的诊断和治疗,仍是提高肾移植成活率的重要课题。 一、急往排斥的诊断 急性排斥多发生于肾移植后半年内,偶有发生于术后8年的报告。
Kidney transplantation is an effective treatment for end-stage renal disease. At present, some hospitals in China have achieved good results in kidney transplantation. The 1-year survival rates of patients and renal transplant recipients after kidney transplantation are 93.3% -93.7% and 78.8% -83.7%, respectively, reaching the international advanced level. However, immunology has not yet been fully resolved, about 1 to 6 months after renal transplantation in about 75% of patients may occur 1 to 3 times acute rejection, which is the leading cause of renal graft loss, accounting for 73.5 % ~ 94.8%. Therefore, the emphasis on the diagnosis and treatment of acute rejection is still an important issue to improve the survival rate of renal transplantation. First, the diagnosis of acute rejection of acute rejection occurred more than six months after renal transplantation, Occasional occurred in 8 years after the report.